Total trials
395
Active
86
Phase 3
15
Total enrollment
214,788
Pipeline matrix
Showing 27 of 27 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Midazolam | — | — | — | — | — | 1 | |
| Sufentanil | — | — | — | — | — | 1 | |
| Propofol | — | — | — | — | — | 1 | |
| tranexamic acid Oral-Short Arm | — | — | — | — | — | 1 | |
| tranexamic acid Oral-Long Arm | — | — | — | — | — | 1 | |
| Control group placebo | — | — | — | — | — | 1 | |
| Losartan | — | — | — | — | — | 1 | |
| Methylprednisolone | — | — | — | 6 | |||
| Chlorhexidine | — | — | — | — | — | 1 | |
| Gentamicin | — | — | — | — | — | 1 | |
| Rifampin | — | — | — | — | — | 1 | |
| Saline | — | — | — | 5 | |||
| Ketorolac | — | — | — | 3 | |||
| oral ibuprofen | — | — | — | — | — | 1 | |
| Lidocaine HCl 1% | — | — | — | — | — | 1 | |
| Probiotic Agent | — | — | — | — | — | 1 | |
| Nicotine Replacement Therapy (NRT) Sampling | — | — | — | — | — | 1 | |
| Esomeprazole 40 mg | — | — | — | — | — | 1 | |
| Ketamine | — | — | — | — | — | 1 | |
| (2R,6R)-hydroxynorketamine | — | — | — | — | — | 1 | |
| Naloxone | — | — | — | — | — | 1 | |
| Stellate Ganglion Block | — | — | — | — | — | 1 | |
| Tranexamic Acid Injectable Product | — | — | — | — | — | 1 | |
| Vitamin C 250 MG Oral | — | — | — | — | — | 1 | |
| Tranexamic Acid 650Mg | — | — | — | — | — | 1 | |
| Bone Marrow Aspirate Concentrate | — | — | — | — | — | 1 | |
| Corticosteroid injections | — | — | — | — | — | 1 |
Next readouts
- 2024-11-29
- 2026-05
- 2026-05-31
- 2026-11
- 2026-11-30
- 2026-12
- 2026-12-01
- 2026-12-01
- 2027-04-30
- 2027-05-30
Top conditions
- Osteoarthritis13
- Parkinson Disease11
- Obesity9
- Total Knee Arthroplasty8
- Hypertension7
- Asthma6
- Depression5
- Menopause5
Frequently asked questions about Rush University Medical Center
- How many clinical trials does Rush University Medical Center have on ClinicalTrials.gov?
- Rush University Medical Center is listed as the lead sponsor on 395 clinical trials in ClinicalTrials.gov, 86 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Rush University Medical Center's trials are in Phase 3?
- 15 of Rush University Medical Center's trials are in Phase 3, spread across 27 active drug programs.
- What therapeutic areas does Rush University Medical Center focus on?
- Rush University Medical Center's most-studied conditions on ClinicalTrials.gov are Osteoarthritis, Parkinson Disease, Obesity, Total Knee Arthroplasty, Hypertension.
- When are Rush University Medical Center's next clinical trial readouts?
- Rush University Medical Center has 10 upcoming primary-completion readouts tracked here; the soonest is “Efficacy of Spinal Manipulation Therapy or Mindfulness-based Reduction Therapy on Patients With Chronic Low Back Pain”, expected around 2024-11-29.